P3 Health Partners (NASDAQ:PIII) Stock Rating Lowered by Zac

P3 Health Partners (NASDAQ:PIII) Stock Rating Lowered by Zacks Investment Research

P3 Health Partners (NASDAQ:PIII – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., […]

Related Keywords

Nevada , United States , Michael Balkin , William Blair , Penserra Capital Management , Geode Capital Management , Health Partners , Zacks Investment Research , Foresight Acquisition Corp , Health Partners Company Profile Get Rating , Blair William Co , Citadel Advisors , Health Partners Inc , Get Rating , Capital Management , Partners Company Profile , Partners Inc , P3 Health Partners , Nasdaq Piii , Opiii , Medical , Downgrade ,

© 2025 Vimarsana